Main Subject - Business

Throughout my entire pharmaceutical career as a drug rep as well as a manager, I’ve observed how some drug reps have been r

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

egarded by medical professionals as respectable while other drug reps were treated as if they were just annoying sales peop

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

le.

The main thing that separates those drug reps that doctors, pharmacists and nurses respect from all the others is the

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

knowledge the seasoned sales pros are able to communicate. The super drug reps know their stuff inside out including the p

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

armacology of their products, the medical aspects and the clinical studies that involve the therapeutic areas of interest.

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

The clinical studies are especially important as doctors seem to respect drug reps that are currently on top of all releva

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

nt published medical literature. It is quite evident that top drug reps have really done their homework in terms of knowin

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

g everything important about the therapeutic areas they are involved in. Such drug reps become reporters to help doctors k

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ep current and are therefore regarded as an important part of the overall health care team.

Drug reps must be able to conv

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

erse with doctors at the highest levels with respect to clinical studies. To be able to do this, the reps must be familiar

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

with every last detail of clinical studies and be ready to discuss them with medical professionals. This will certainly g

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ain the respect of even some of the most highly regarded specialist physicians.

Mediocre drug reps are not comfortable wit

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

clinical studies and are not current with what’s published in the literature. These reps rely solely on promotional sales

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

material and are therefore not regarded as highly as their counterparts who can really communicate at the same levels as p

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

hysicians.

As a former pharmaceutical sales manager, I’ve always made sure that the drug reps I managed were always up to

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

date with published medical literature and they were able to go through relevant clinical studies with great ease during th

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ir visits with doctors.

If you are an aspiring drug rep who wants to enter the pharmaceuticals sales industry, one of the

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

discussion areas during your job interviews could be on the prospective company’s training department. You could ask how w

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ell they train their sales force on medical literature and how they ensure that their drug reps are kept current on all imp

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ortant relevant issues. You will come across as someone who wants to be taken seriously and respected by medical customers

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/39373/mainsubjects-How-Drug-Reps-Can-Become-Respectable.html">How Drug Reps Can Become Respectable</a>

BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/39373/mainsubjects-How-Drug-Reps-Can-Become-Respectable.html]How Drug Reps Can Become Respectable[/url]

In the hospitality industry, customer service is the platform upon which everything is built. It's the mantra. It must become a core competency. So, if it's all about customer service which is designed to build relationship equity with your firm; your brand which in turn creates customer loyalty, are cookies, coffee and the USA enough? I think not.

Reducing defects is a noble goal, but not at the cost of sacrificing sales growth. The bottom line is profits and with Six Sigma that can be lost in a fuzzy haze of measuring defects instead of profits.

In our busy world of voice mails and emails, it's hard to connect with people on the phone. You can use these simple tips to get more of your calls returned.

Tags

Links

Main Subject - How Drug Reps Can Become Respectable

Related Articles: